Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

PROSCA/BLADDR 2020 | NMIBC: relevance of prognostic markers

Amir Mostafid, MSc, FRCS, FEBU, Royal Surrey County Hospital, Guildford, Surrey, UK, discusses the relevance, benefits and the challenges of using urine-based prognostic biomarkers for the detection and management of non-muscle invasive bladder cancer (NMIBC). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).